PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma | Journal of Experimental & Clinical Cancer Research | Full Text

PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma | Journal of Experimental & Clinical Cancer Research | Full Text

PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma

Therapeutic options for patients with hepatocellular carcinoma (HCC) are limited. Transarterial chemoembolization (TACE) is an interventional procedure used to deliver chemotherapy and embolizing agents direct...

Authors:Sean P. Martin, Valerie Fako, Hien Dang, Dana A. Dominguez, Subreen Khatib, Lichun Ma, Haiyang Wang, Wei Zheng and Xin Wei Wang

Citation:Journal of Experimental & Clinical Cancer Research 2020 39:99

Content type:Research

 

Published on: 3 June 2020

• ViewFull Text
 
• ViewPDF